BioNTech SE (22UAy)

Frankfurt


	Symbol		Exchange		Currency
	BNTX		NASDAQ		USD	Real-time
	BNTXN		BIVA		MXN	Delayed
	22UAy		Xetra		EUR	Delayed
	22UAy		Frankfurt		EUR	Delayed
	22UAy		TradeGate		EUR	Delayed
	B1NT34		B3		BRL	Delayed
	BNTX		Vienna		EUR	Real-time

Currency in EUR

Disclaimer

110.10

+0.40(+0.36%)

Closed04/10

Fair Value

Day's Range

108.10

111.50

52 wk Range

69.70

117.20

22UAy Income Statement

Featured here, the Income Statement (earnings report) for BioNTech SE, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

17,310.6

3,819

Total Revenues Growth

-8.78%

-77.94%

Cost Of Revenues

2,995

599.8

Gross Profit

14,315.6

3,219.2

Gross Profit Growth

-10.89%

-77.51%

Gross Profit Margin %

82.7%

84.29%

Other Operating Expenses, Total

2,398.7

2,249.6

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+76.91%	-6.22%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,537	1,783.1
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	541.2	557.7
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	320.5	-91.2

Operating Income

11,916.9

969.6

Operating Income Growth

-18.98%

-91.86%

EBIT Margin %

68.84%

25.39%

Net Interest Expenses

29.6

349.7

Net Interest Expenses Growth

+214.73%

+1,081.42%

Interest Expense, Total

-18.9

-7.9

Interest And Investment Income

48.5

357.6

Other Non Operating Expenses, Total

1,009.2

-106

EBT, Excl. Unusual Items

12,955.7

1,213.3

Gain (Loss) On Sale Of Assets

-

-

Other Unusual Items, Total

-1.6

-27.2

EBT, Incl. Unusual Items

12,954.1

1,186.1

EBT, Incl. Unusual Items Growth

-13.91%

-90.84%

EBT, Incl. Unusual Items Margin

74.83

31.06

Income Tax Expense

3,519.7

255.8

Net Income to Company

9,434.4

930.3

Minority Interest

-

-

Net Income

9,434.4

930.3

Net Income Growth

-8.34%

-90.14%

Net Income Margin %

54.5%

24.36%

Preferred Dividend and Other Adjustments

-

-

Net Income to Common Excl. Extra Items

9,434.4

930.3

Basic EPS - Continuing Operations

38.78

3.87

Basic EPS - Continuing Operations Growth

-8.07%

-90.03%

Diluted EPS - Continuing Operations

37.77

3.83

Diluted EPS - Continuing Operations Growth

-4.69%

-89.86%

Basic Weighted Average Shares Outstanding

243.3

240.6

Diluted Weighted Average Shares Outstanding

249.8

242.7

Dividend Per Share

-

-

Dividend Per Share Growth

-

-

EBITDA

11,981.4

1,107.8

EBITDA Growth

-18.8%

-90.75%

EBITDA Margin %

69.21%

29.01%

EBIT